Brain natriuretic peptide is unchanged after 4 weeks of continuous positive airway pressure therapy. by Pepperell, J, Stradling, J, Davies, R

Sleep studies for sleep apnoea. by Pepperell, J, Davies, R, Stradling, JR

Sleep apnoea and hypertension: proof at last? by Stradling, JR, Pepperell, J, Davies, R

Sleep apnoea and hypertension: Proof at last? by Stradling, JR, Pepperell, J, Davies, R

Systemic hypertension and obstructive sleep apnoea. by Pepperell, J, Davies, R, Stradling, J

Ambulatory blood pressure after sleep apnoea treatment - Reply by Pepperell, J, Stradling, J, Davies, R

Caffeine levels following treatment of obstructive sleep apnoea. by Robinson, G, Pepperell, J, Davies, R, Stradling, JR

Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. by Kohler, M, Pepperell, J, Davies, R, Stradling, JR

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. by Robinson, G, Pepperell, J, Segal, H, Davies, R, Stradling, JR

Baroreflex sensitivity increases after 4 weeks of nasal continuous positive airway presure therapy in patients with obstructive sleep apnoea by Pepperell, J, Maskell, N, Crosthwaite, N, Stradling, JR, Davies, R

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. by Craig, S, Pepperell, J, Kohler, M, Crosthwaite, N, Davies, R, Stradling, JR

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP) by Pepperell, J, Mullins, B, Dow, SR, Crosthwaite, N, Stradling, JR, Davies, R

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment by Robinson, G, Pepperell, J, Segal, H, Langford, B, Davies, R, Stradling, JR

Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. by Siccoli, M, Pepperell, J, Kohler, M, Craig, SE, Davies, R, Stradling, JR

CPAP and measures of cardiovascular risk in males with OSAS. by Kohler, M, Pepperell, J, Casadei, B, Craig, S, Crosthwaite, N, Stradling, JR, Davies, R

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. by Pepperell, J, Ramdassingh-Dow, S, Crosthwaite, N, Mullins, R, Jenkinson, C, Stradling, JR, Davies, R

Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. by Maskell, N, Waine, D, Lindley, A, Pepperell, J, Wakefield, A, Miller, R, Davies, R

A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. by Pepperell, J, Maskell, N, Jones, DR, Langford-Wiley, B, Crosthwaite, N, Stradling, JR, Davies, R

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial. by Kohler, M, Craig, S, Pepperell, J, Nicoll, D, Bratton, D, Nunn, A, Leeson, P, Stradling, JR

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL by Kohler, M, Craig, SE, Pepperell, J, Nicoll, D, Bratton, D, Nunn, A, Davies, R, Stradling, JR